Inhibition of a lower potency target drives the anticancer activity of a clinical p38 inhibitor is a research paper published in Cell chemical biology (2023). On theSindex it has a DataRank of 0.483. It has been cited 24 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.483
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →U.S. Department of Defense
Grant: W81XWH-20-1-068
NIH
Grant: UL1TR001412-07
NIH
Grant: R01CA237652
NCI NIH HHS
Grant: R01 CA198164
NCATS NIH HHS
Grant: UL1 TR001412
NCI NIH HHS
Grant: R03 CA259881
American Cancer Society
National Center for Advancing Translational Sciences
State University of New York
Fields of Study
MeSH Terms
Keywords